GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Cyclically Adjusted Revenue per Share

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Cyclically Adjusted Revenue per Share : ¥1.42 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Tonghua Dongbao Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥0.303. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥1.42 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Tonghua Dongbao Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 4.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Tonghua Dongbao Pharmaceutical Co was 19.20% per year. The lowest was 8.00% per year. And the median was 13.00% per year.

As of today (2024-06-18), Tonghua Dongbao Pharmaceutical Co's current stock price is ¥9.07. Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥1.42. Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 6.39.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tonghua Dongbao Pharmaceutical Co was 39.33. The lowest was 6.34. And the median was 15.97.


Tonghua Dongbao Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Tonghua Dongbao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.03 1.12 1.25 1.34 1.41

Tonghua Dongbao Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 1.37 1.39 1.41 1.42

Competitive Comparison of Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Tonghua Dongbao Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tonghua Dongbao Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.303/115.2271*115.2271
=0.303

Current CPI (Mar. 2024) = 115.2271.

Tonghua Dongbao Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.188 98.200 0.221
201409 0.215 98.900 0.250
201412 0.242 99.000 0.282
201503 0.227 99.900 0.262
201506 0.249 99.500 0.288
201509 0.277 100.500 0.318
201512 0.259 100.600 0.297
201603 0.272 102.200 0.307
201606 0.270 101.400 0.307
201609 0.344 102.400 0.387
201612 0.334 102.600 0.375
201703 0.336 103.200 0.375
201706 0.355 103.100 0.397
201709 0.394 104.100 0.436
201712 0.405 104.500 0.447
201803 0.420 105.300 0.460
201806 0.308 104.900 0.338
201809 0.253 106.600 0.273
201812 0.354 106.500 0.383
201903 0.339 107.700 0.363
201906 0.362 107.700 0.387
201909 0.319 109.800 0.335
201912 0.353 111.200 0.366
202003 0.363 112.300 0.372
202006 0.373 110.400 0.389
202009 0.332 111.700 0.342
202012 0.361 111.500 0.373
202103 0.416 112.662 0.425
202106 0.399 111.769 0.411
202109 0.382 112.215 0.392
202112 0.403 113.108 0.411
202203 0.438 114.335 0.441
202206 0.252 114.558 0.253
202209 0.355 115.339 0.355
202212 0.340 115.116 0.340
202303 0.345 115.116 0.345
202306 0.332 114.558 0.334
202309 0.370 115.339 0.370
202312 0.513 114.781 0.515
202403 0.303 115.227 0.303

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Tonghua Dongbao Pharmaceutical Co  (SHSE:600867) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.07/1.42
=6.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Tonghua Dongbao Pharmaceutical Co was 39.33. The lowest was 6.34. And the median was 15.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Tonghua Dongbao Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Traded in Other Exchanges
N/A
Address
Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
Executives
Cheng Jian Qiu Supervisors
Chang Xiao Hui Director
Li Cong Director
Li Feng Qin Director
Chen Hong senior management
Leng Chun Sheng Director
Li Yi Kui Director
Wang Dian Duo Supervisors
Wang Jun Ye Director
Han Jie Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines